Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07384429
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Study for the Dual Orexin Receptor Antagonist Lemborexant in Improving Motor-Sleep Comorbidity in Parkinson's Disease
Sponsor: Eisai China Inc.
Conditions
Insomnia Motor Disorder Parkinson's Disease
Interventions
Lemborexant placebo
Updated 1 time since 2026 Last updated: Feb 3, 2026 Started: Feb 4, 2026 Primary completion: Dec 1, 2026 Completion: Dec 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Insomnia and Motor Disorder, this trial is actively recruiting participants. The trial is conducted by Eisai China Inc. and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Eisai China Inc.
- Nanjing University
- YangPan
Data source: Zhongnan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.